Medical devices employing novel polymers
First Claim
Patent Images
1. A medical device having at least one surface, comprising:
- a first polymer on all or a portion of the surface;
wherein the polymer comprises at least one active agent incorporated into the polymer backbone, and wherein a first active agent is disassociated from the polymer upon hydrolysis.
3 Assignments
0 Petitions
Accused Products
Abstract
Medical devices with at least one surface comprising a polymer or polymers on the surface are provided. The polymer or polymers are capable of breaking down (e.g., including, but not limited to, hydrolyzing) in the physiologic milieu to form an active agent or agents under physiologic conditions, and can contain other active agents dispersed within or appended to the polymer matrix. Methods of delivering an active agent to an interior surface of a vein or artery are also provided.
111 Citations
79 Claims
-
1. A medical device having at least one surface, comprising:
- a first polymer on all or a portion of the surface;
wherein the polymer comprises at least one active agent incorporated into the polymer backbone, and wherein a first active agent is disassociated from the polymer upon hydrolysis. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)
- a first polymer on all or a portion of the surface;
-
22. A medical device having at least one surface, comprising:
- a first polymer and a second polymer on all or a portion of the surface, wherein the first polymer is capable of breaking down in the physiologic milieu to form a first active agent, and the second polymer is capable of breaking down in the physiologic milieu to form a second active agent.
- View Dependent Claims (23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)
-
38. A medical device having at least one surface, comprising:
- a first polymer and a second polymer on all or a portion of the surface, a first polymer and a second polymer on all or a portion of the surface, wherein the first polymer is capable of breaking down in the physiologic milieu to form a first active agent, and the second polymer is capable of hydrolyzing to form a second active agent, wherein the first and second active agents combine in vivo to form a third active agent.
-
39. A stent having at least one surface, comprising:
- a first polymer on all or a portion of the surface, wherein a first active agent is disassociated from the polymer upon hydrolysis.
- View Dependent Claims (40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58)
-
59. A method for delivering an active agent to an interior surface of a vein or an artery, comprising:
-
providing a medical device having at least one surface, comprising;
a first polymer on all or a portion of the surface, wherein a first active agent is disassociated from the polymer upon hydrolysis; and
positioning the medical device at or near the interior surface of the vein or the artery;
wherein the first active agent is disassociated from the polymer upon hydrolysis and delivered to the interior surface of the vein or artery. - View Dependent Claims (60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79)
-
Specification